Aardvark Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - AARD
NEW YORK, Oct. 12, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action lawsuit against Aardvark Therapeutics, Inc. ("Aardvark" or "the Company") (NASDAQ: AARD) violations of the federal securities laws. Shareholders who purchased shares of AARD during the class...
Covered in this story
What has happened since
- Aardvark Therapeutics Inc is down 12.4% since this was published, 8 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $AARD yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Aardvark Therapeutics Inc →Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.